Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more
Hengkang Medical Group Co Ltd (002219) - Total Liabilities
Latest total liabilities as of September 2025: CN¥4.53 Billion CNY
Based on the latest financial reports, Hengkang Medical Group Co Ltd (002219) has total liabilities worth CN¥4.53 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hengkang Medical Group Co Ltd - Total Liabilities Trend (2004–2024)
This chart illustrates how Hengkang Medical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hengkang Medical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hengkang Medical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
zooplus AG
PINK:ZLPSF
|
USA | $459.04 Million |
|
Schrodinger Inc
NASDAQ:SDGR
|
USA | $332.31 Million |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MC:LDA
|
Spain | €970.25 Million |
|
Foshan Saturday Shoes Co Ltd
SHE:002291
|
China | CN¥1.94 Billion |
|
Jiangyin Jianghua Microelectronics Materials Co Ltd
SHG:603078
|
China | CN¥684.35 Million |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
USA | $21.34 Million |
|
Inv La Constru
SN:ILC
|
Chile | CL$16.08 Trillion |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
USA | $95.74 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Hengkang Medical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hengkang Medical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hengkang Medical Group Co Ltd (2004–2024)
The table below shows the annual total liabilities of Hengkang Medical Group Co Ltd from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥4.64 Billion | +20.56% |
| 2023-12-31 | CN¥3.85 Billion | -0.80% |
| 2022-12-31 | CN¥3.88 Billion | -24.05% |
| 2021-12-31 | CN¥5.10 Billion | +9.46% |
| 2020-12-31 | CN¥4.66 Billion | -0.84% |
| 2019-12-31 | CN¥4.70 Billion | -20.32% |
| 2018-12-31 | CN¥5.90 Billion | -0.07% |
| 2017-12-31 | CN¥5.91 Billion | +225.90% |
| 2016-12-31 | CN¥1.81 Billion | +85.39% |
| 2015-12-31 | CN¥977.44 Million | +16.91% |
| 2014-12-31 | CN¥836.05 Million | +159.41% |
| 2013-12-31 | CN¥322.29 Million | +4.49% |
| 2012-12-31 | CN¥308.45 Million | +149.48% |
| 2011-12-31 | CN¥123.64 Million | +24.66% |
| 2010-12-31 | CN¥99.18 Million | +1.35% |
| 2009-12-31 | CN¥97.86 Million | +108.60% |
| 2008-12-31 | CN¥46.91 Million | -49.93% |
| 2007-12-31 | CN¥93.70 Million | +19.55% |
| 2006-12-31 | CN¥78.38 Million | +15.29% |
| 2005-12-31 | CN¥67.99 Million | -15.99% |
| 2004-12-31 | CN¥80.92 Million | -- |